BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18517086)

  • 1. Patients with abnormal IgM levels: assessment, clinical interpretation, and treatment.
    Ochs HD
    Ann Allergy Asthma Immunol; 2008 May; 100(5):509-11. PubMed ID: 18517086
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features.
    Lougaris V; Badolato R; Ferrari S; Plebani A
    Immunol Rev; 2005 Feb; 203():48-66. PubMed ID: 15661021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients.
    Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME
    Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow transplantation as treatment for X-linked immunodeficiency with hyper-IgM.
    Bordigoni P; Auburtin B; Carret AS; Schuhmacher A; Humbert JC; Le Deist F; Sommelet D
    Bone Marrow Transplant; 1998 Dec; 22(11):1111-4. PubMed ID: 9877275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation.
    Thomas C; de Saint Basile G; Le Deist F; Theophile D; Benkerrou M; Haddad E; Blanche S; Fischer A
    N Engl J Med; 1995 Aug; 333(7):426-9. PubMed ID: 7542361
    [No Abstract]   [Full Text] [Related]  

  • 6. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
    Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
    Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyper IgM Syndrome with low IgM and thrombocytosis: an unusual case of immunodeficiency.
    Yousef E; Arshad Alvi M
    Eur Ann Allergy Clin Immunol; 2016 Sep; 48(5):194-6. PubMed ID: 27608476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment and clinical interpretation of reduced IgG values.
    Agarwal S; Cunningham-Rundles C
    Ann Allergy Asthma Immunol; 2007 Sep; 99(3):281-3. PubMed ID: 17910333
    [No Abstract]   [Full Text] [Related]  

  • 9. ARDS as presenting symptom in an infant with CD40L deficiency (Hyper-IgM syndrome Type 1).
    Fremerey C; Wiebe B; Feyen O; Lenski C; Pohlmann U; Ehlen M; Schofer O; Meindl A; Niehues T; Bartmann P
    Klin Padiatr; 2009 Sep; 221(5):302-4. PubMed ID: 19707993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperimmunoglobulin syndrome due to CD40 deficiency: possibly the first case from India.
    Mishra A; Italia K; Gupta M; Desai M; Madkaikar M
    J Postgrad Med; 2015; 61(1):46-8. PubMed ID: 25511220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome.
    Sacco MG; Ungari M; Catò EM; Villa A; Strina D; Notarangelo LD; Jonkers J; Zecca L; Facchetti F; Vezzoni P
    Cancer Gene Ther; 2000 Oct; 7(10):1299-306. PubMed ID: 11059686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hyper IgM syndrome.
    Fuleihan RL
    Curr Allergy Asthma Rep; 2001 Sep; 1(5):445-50. PubMed ID: 11892071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyper-immunoglobulin M syndrome caused by a mutation in the promotor for CD40L.
    Van Hoeyveld E; Zhang PX; De Boeck K; Fuleihan R; Bossuyt X
    Immunology; 2007 Apr; 120(4):497-501. PubMed ID: 17244160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyper IgM syndrome: the other side of the coin.
    Fuleihan RL
    Curr Opin Pediatr; 2001 Dec; 13(6):528-32. PubMed ID: 11753101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Type 1 hyper-IgM syndrome diagnosed in a 28-year-old patient with recurrent infections since childhood].
    Koike M; Oshimi K; Agematu K; Futani T
    Rinsho Ketsueki; 2006 Oct; 47(10):1377-80. PubMed ID: 17094577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer.
    Subauste CS; Wessendarp M; Sorensen RU; Leiva LE
    J Immunol; 1999 Jun; 162(11):6690-700. PubMed ID: 10352287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From gene to disease; CD40 ligand deficiency as the cause of X-linked hyper-IgM-syndrome].
    Groeneweg M; Lankester AC; Bredius RG
    Ned Tijdschr Geneeskd; 2003 May; 147(21):1009-11. PubMed ID: 12811971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome.
    Bajorath J; Seyama K; Nonoyama S; Ochs HD; Aruffo A
    Protein Sci; 1996 Mar; 5(3):531-4. PubMed ID: 16509032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evolving view of hyper-IgM syndrome.
    Conley ME
    J Pediatr; 1997 Jul; 131(1 Pt 1):8-9. PubMed ID: 9255183
    [No Abstract]   [Full Text] [Related]  

  • 20. Hyper-IgM syndrome: a case report.
    Wang IJ; Wang SJ; Yan DC; Lin SJ; Chiang BL
    J Microbiol Immunol Infect; 2003 Sep; 36(3):215-7. PubMed ID: 14582569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.